|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online March 9, 2005 as doi:10.1096/fj.04-2117fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Ilsong Institute of Life Science, Anyang, Kyounggi-do, South Korea;
Department of Veterinary Medicine, Kangwon National University, Chuncheon, Kangwon-do, South Korea; and
New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, USA
1 Correspondence: Ilsong Institute of Life Science and Department of Microbiology, College of Medicine, Hallym University, Ilsong Building, 1605-4 Gwanyang-dong, Dongan-gu Anyang, Kyounggi-do 431-060, South Korea. E-mail: yskim{at}hallym.ac.kr
SPECIFIC AIMS
Transition metals, which have a redox capacity, have been implicated in metal-catalyzed oxidation (MCO) of proteins, which can lead to structural alteration or aggregation of these proteins. We hypothesized that transition metals such as Mn and molecules oxidized by MCO would be cofactors for PrPres formation. This concept was supported by our finding that the level of Mn was significantly increased in brain homogenates, mitochondrial fractions of brain and PrPSc-enriched fractions obtained from scrapie-positive animals. Thus, we focused on Mn in the formation of PrPres by several cycles of incubation-sonication; we tested the effect of addition of Cu and Fe to the incubation-sonication reaction. The aim of this study was to investigate whether transition metals and deoxycholic acid (DA), an oxidized molecule, can induce PrPres amplification in normal brain homogenate in vitro.
PRINCIPAL FINDINGS
1. Increase of Mn level in the scrapie-infected hamster brain
Total Mn levels in whole brain of 263K scrapie-infected hamster brains were significantly higher than in control brain preparations (33.8% higher, P<0.01). In mitochondrial fractions from 263K brains, Mn levels were higher than in control mitochondrial fractions (32.8% higher, P<0.01). The Mn levels were also higher in sarkosyl supernatants from scrapie brain preparations compared with preparations from normals (34.5%, P<0.05). In contrast, there was no difference in the Mn levels in NaCl-treated preparations between scrapie and control. Sarkosyl extracts of scrapie brain are rich in scrapie-associated fibrils (SAF), whereas SAF are not found in supernatants after NaCl treatment.
2. PrPres induced by modified PMCA and inhibition of PrPres formation by EDTA
We applied the new technique of protein misfolding cyclic amplification (PMCA) to PrPC using cycles of incubation-sonication with Mn-treated normal hamster brain homogenate but without the PrPSc seed used in standard PMCA. We used several cycles of incubation-sonication plus an additional incubation of Mn-treated normal brain homogenate; this protocol is termed modified PMCA. In incubation-only cycles (0 cycles), PrPres in the homogenate treated with 350 mM MnCl2 was detected with proteinase K (PK) doses of up to 50 µg/mL; PrPres was not detected at lower levels of MnCl2. In contrast, using four cycles of modified PMCA in the presence of 350 mM MnCl2, PrPres was resistant to PK at doses of up to 250 µg/mL. At lower MnCl2 doses, using one or four cycles of modified PMCA at different power amplitudes (20, 30, and 60%), PrPres was detected, whereas no PrPres was found after 0 cycles. By performing in vitro deglycosylation with PNGase F, we found that PrPres produced in the presence of Mn by modified PMCA was glycosylated. The banding pattern seen in Cu- or Fe-treated samples was different from that found in Mn-treated samples after one cycle of modified PMCA. The major difference is that with Cu- or Fe-treated samples there was a band consistently found at 2930 kDa that was not routinely found with Mn treatment. The induction of PrPres by modified PMCA with Mn was reversed by EDTA, a metal chelater, suggesting PrPres production results from Mn. The effect of Mn in the modified PMCA was not a function of the acidity of the MnCl2 solution used. Induction of PrPres by Mn occurred at incubation temperatures of 37°C and 65°C.
3. Effect of DA on the Mn-induced PrPres by modified PMCA
We examined whether the composition of the immunoprecipitation (IP) buffer might influence Mn-induced PrPres formation in the modified PMCA. We compared one cycle of modified PMCA using various doses of Mn with different buffers. Solutions such as PBS and distilled water did not permit PrPres formation. We found that elimination of DA from the IP buffer yielded markedly reduced levels of PrPres formation whereas in IP buffers without Triton X-100 or NaCl, there was not a profound effect (Fig. 1
A). The Mn-induced PrPres signal increased in IP buffer as a function of increasing concentrations of DA (Fig. 1B
), whereas PrPres signal was not found using DA alone (i.e., without MnCl2 or at a pH range (6.65
7.87) comparable to the pH of the DA solution) (Fig. 1C
). Acids such as DA or HEPES are needed in Mn-induced PrPres formation by modified PMCA.
|
4. The PrPres produced by modified PMCA in the presence of Mn and DA can act as a template for further PrPres production
Putative PrPres templates were produced by modified PMCA in the presence of Mn plus DA. These preparations were diluted in normal hamster brain homogenates and these mixtures were subjected to 10 cycles of incubation-sonication (standard PMCA but without the PrPSc seed). PrPres signals after 10 PMCA cycles could be diluted further than preparations incubated without sonication (Fig. 2
). PrPres amplification was detected even after a 2560-fold dilution of template, whereas the end point for the incubation-only samples was 320-fold. We also found that EDTA added to the solution used in the modified PMCA reaction eliminated the template effect of the preparation (Fig. 2)
.
|
CONCLUSIONS AND SIGNIFICANCE
Certain cofactors may play a role in the conformational change of PrP isomers that occurs during the course of scrapie pathogenesis. Studies of PrPres complex bound to metals by MCO are expected to provide new insight into the PrPC
PrPSc conversion mechanism in prion diseases. In the present study, PrPres amplification by modified PMCA required both Mn and oxidized molecules such as DA (Fig. 1)
. In scrapie-infected hamsters, the level of Mn was increased in whole brain, mitochondria, and SAF-enriched fraction compared with the values in preparations from the control group.
On the basis of our results, we suggest that PK-resistant PrPC-Mn complex is formed through binding of PrPC to Mn in the presence of DA in IP buffer. This PrP-metal complex would be partially resistant to PK and could provide a template for further PrPres formation in a PMCA-type reaction (Fig. 3
).
|
Carboxyl acids such as 3-aminophenylacetic acid and valproic acid are oxidized molecules similar to DA; these molecules have been shown to exacerbate amyloid-like fibril formation or accumulation. In our study, PrPres formation was not found in DA alone, but required Mn plus DA. Mn and oxidized molecules such as carboxyl acids may be involved in the mechanism of PrPC conversion to PrPSc.
MCO may be involved in human neurological disorders and, as described by others, may cause structural alteration, dysfunction, and aggregation of proteins. In prion diseases, previous studies have shown that PrP is prone to MCO, resulting in conformational changes or aggregation in vitro. These findings suggest that PrPC may be converted to an oxidized form by transition metals and that this is an important pathogenic mechanism in prion diseases. The precise mechanism of metal-catalyzed PrP oxidation remains to be determined.
Use of the modified PMCA technique may provide insight into the roles of metals and oxidized molecules in PrPres amplification.
FOOTNOTES
To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.04-2117fje;
This article has been cited by other articles:
![]() |
M. W. Brazier, P. Davies, E. Player, F. Marken, J. H. Viles, and D. R. Brown Manganese Binding to the Prion Protein J. Biol. Chem., May 9, 2008; 283(19): 12831 - 12839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basu, M. L. Mohan, X. Luo, B. Kundu, Q. Kong, and N. Singh Modulation of Proteinase K-resistant Prion Protein in Cells and Infectious Brain Homogenate by Redox Iron: Implications for Prion Replication and Disease Pathogenesis Mol. Biol. Cell, September 1, 2007; 18(9): 3302 - 3312. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hopp, M. K. Omer, and B. T. Heier A case-control study of scrapie Nor98 in Norwegian sheep flocks J. Gen. Virol., December 1, 2006; 87(12): 3729 - 3736. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Varela-Nallar, E. M. Toledo, L. F. Larrondo, A. L. B. Cabral, V. R. Martins, and N. C. Inestrosa Induction of cellular prion protein gene expression by copper in neurons Am J Physiol Cell Physiol, January 1, 2006; 290(1): C271 - C281. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |